I generally don't reply... but in this case I will .. your...

I generally don't reply... but in this case I will ..

your arguments are very naive . It's like saying why these exploration companies are allowed to list .. there should be only producers or JORC resources companies should be allowed to list!

Most mid cap/Large cap biotechs /Med techs listed as proof of concept and Nothing else I.e . PAR PME NAN etc

Even CSL originally floated in 1994 when it was just bunch of ideas with a lot to prove and in next 25 years given all the share buybacks the company has embarked on, the adjusted entry price is equivalent to around 76 cents. An initial $10,000 investment in CSL would now be worth over $1.3 million with more than $140,000 dividends paid in that time and SP is $ 300.

Every company starts small .. some fail and some don't..

Winners have some similar characteristics though I.e. Great Management team , Solid long term investors, Some great early stage ideas , and IMO Nyrada ticks lot of these boxes.

Let's wait and watch

Time will tell

GLTAL

DYOR